Search results for “Proprotein Convertase Inhibitors” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,030 patents, we discovered top 78 key players by total patent application. Amgen, Inc., Regeneron Pharmaceuticals, Inc., Novartis AG are dominant in this area. They take 42.33% of the total patent filing.
Amgen, Inc.
California, United States
Patent: 201
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 159
Novartis AG
Basel-Stadt, Switzerland
Patent: 76
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 57
Pfizer Inc.
New York, United States
Patent: 35
Roche Innovation Center Copenhagen A/S
Hovedstaden, Denmark
Patent: 30
Rinat Neuroscience Corp.
California, United States
Patent: 29
Sanofi SA
France
Patent: 28
Shifa Biomedical Corp.
Pennsylvania, United States
Patent: 28
Srx Cardio LLC
New York, United States
Patent: 27
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 4 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 4
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 274 patents applied in the last 5 years. We discover 50 most active companies in this area. The fast-growing Novartis AG, Regeneron Pharmaceuticals, Inc., Amgen, Inc. take 29.20% of patent filing during this period.
Novartis AG
Basel-Stadt, Switzerland
Patent: 30
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 29
Amgen, Inc.
California, United States
Patent: 21
Srx Cardio LLC
New York, United States
Patent: 15
Kymab Ltd.
Cambridgeshire, United Kingdom
Patent: 13
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 10
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 10
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 9
Ra Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 9
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Shi, China
Patent: 8
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 274 patents in last 5 years, we discover 30 new entrants. Suzhou Ruibo Biological Technology Co Ltd, Ra Pharmaceuticals, Inc., LIB Therapeutics LLC are the most active new entrants in this area.
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 10
Ra Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 9
LIB Therapeutics LLC
Delaware, United States
Patent: 8
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 6
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 5
Argonaute RNA Ltd.
BRISTOL, United Kingdom
Patent: 5
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 5
The Kitasato Institute
Japan
Patent: 5
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 5
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 4
Research Institutions
Order by:
Innovation Intensity
With the analysis among 84 patents, we discovered top 15 universities and scientific research institutions by total patent application. McGill University, Philipps University of Marburg, Icahn School of Medicine at Mount Sinai are dominant in this area. They take 38.10% of the total patent filing.
McGill University
Ontario, Canada
Patent: 4
Philipps University of Marburg
Hessen, Germany
Patent: 4
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 4
University of Bordeaux 1
Bretagne, France
Patent: 3
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 3
École Polytechnique Fédérale de Lausanne
Vaud, Switzerland
Patent: 2
New Jersey Institute of Technology
New Jersey, United States
Patent: 2
Chongqing Medical University
Chongqing Shi, China
Patent: 2
Sichuan University
Sichuan Sheng, China
Patent: 1
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: